乌鸦传媒視頻

A three-question quiz on JAK inhibitors, differential diagnoses, and managing AD in infants

Studies show that early disease control lowers risk of developing other atopic morbidities

Dupilumab failure signals the need for extended patch testing to identify a missed diagnosis

Strong efficacy data for new class of agents in AD, but some apprehension over safety warnings

Controlling underlying disease symptoms is the key to improving sleep